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1. Introduction
1.1. Infectious vasculitis
The vasculitides are a heterogeneous group of clinicopathological entities that share the
common feature of vascular inflammation and injury. There is no universally acceptable
classification of this group of disorders. While a number of underlying causes can be identified
in some disorders, the aetiology is unknown in many. The pathogenetic mechanisms involved
are mainly immunological, immune complex mediated tissue injury being the most commonly
incriminated factor.
In 1952, Zeek [1] became the first author to incorporate a clinicopathological assessment based
on the size of the vessels involved in the inflammatory process in her classification of necrot‐
izing vasculitis. A number of alternative classification systems were proposed later and a major
break was made in the 1990s with the 1990 American College of Rheumatology criteria (ACR
1990 criteria); and the elaboration of a uniform terminology for naming, defining, classifying
and diagnosing vasculitic disorders at the Chapel
Hill Conference 1992 (1992 CHC definitions). The 1990 ACR criteria were reviewed in 1996 by
Hunder [2]. The 1992 CHC definitions now include immunodiagnostically significant markers
[e.g. ANCA in Wegener's granulomatosis (WG) and immunohistological findings (e.g. IgA‐
dominant immune deposits in Henoch–Schönlein purpura) which are specific for certain
diseases and were described by Jennette et al. [3]
The major problem with previous classification schemes was the lack of standardized diag‐
nostic terms and definitions. As a consequence, different names had been applied to the same
disease and the same name to different diseases. Therefore, the CHC committee—comprised
of internists, rheumatologists, nephrologists, immunologists and pathologists who have in
common extensive experience with diagnosing vasculitides—proposed the names and
definitions given in Table 3.
© 2013 Choucair; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Immunopathogenesis
Most of the vasculitic syndromes are mediated by immunopathogenic mechanisms (‘immune
vasculitides’) and most ‘immune vasculitides’ are idiopathic (= ‘primary’ vasculitis).
The immunopathogenic mechanisms of vasculitides have been classified into the four types
of hypersensitivity reaction described by Coombs and Gell [4]; this classification was reviewed
recently [5]. Accordingly, clinicopathological and immunohistochemical studies have led to
the terms allergic angiitis (I), antibody‐mediated angiitis, including the ‘new’ group of ANCA‐
associated vasculitides (II), immune complex vasculitis (III), and vasculitis associated with T‐
cell‐mediated hypersensitivity (IV). Eosinophilia and elevated IgE in the blood and tissues (in
situ) are characteristically associated with allergic angiitis and granulomatosis (‘Churg–Strauss
syndrome’; CSS); in ‘ANCA‐associated vasculitides’ (AAV) few or no immune deposits are
found in situ (‘pauci‐immune vasculitis’).
aLarge vessel refers to the aorta and the largest branches directed towards major body regions (e.g. to the extremities
and the head and neck); medium-sized vessel refers to the main visceral arteries (e.g. renal, hepatic, coronary, and
mesenteric arteries); small veseel refers to venules, capillaries, arterioles, and the intraparenchymal distal arterial radicals
that connect with arterioles. Some small and large vessel vasculitides may involve medium-sized arteries,but large- and
medium- sized vessel vasculitides do not involve vessels smaller than arteries. Essential components are represented by
normal type; italicized type represent usual, but not essential components.
bPreffered term.
cStrongly associated with ANCA.
Reproduced from [4] with permission.
Table 1. Names and definitions of vasculitides adopted by the Chapel Hill Concensus Conference on the
Nomenclature of Systemic Vasculitis
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By contrast, immune complex deposits in situ are the hallmark of immune complex vasculitis,
which is frequently associated with low complement levels. Granulomatous arteritis is
characterized by an inflammatory infiltrate induced by Th1 cells. The predominant immune
phenomena in systemic vasculitides associated with the major hypersensitivity reaction type
are given in Fig. 1.
Figure 1. Pease add caption
While some forms of vasculitides may be ascribed to underlying factors like infections,
malignancy, drug reactions or connective tissue disorders, the cause may remain undeter‐
mined in many vasculitic syndromes. Immunologic damage by immune-complex deposition
or cell-mediated hypersensitivity is responsible in the majority of cases.
The possible immunopathologic mechanism in the causation of vasculitis are:
1. Deposition of circulating antigen-antibody complex or in -situ formation of immune
complex within the vessel wall. This leads to complement activation and chemotactic
attraction of neutrophils by complement components. Subsequent phagocytosis of such
complexes with liberation of neutrophil granular products leads to vascular damage.
2. Cell-mediated hypersensitivity: Antigenic exposure may attract lymphocytes which
liberate cytokines causing tissue damage and further activation of macrophages and
lymphocytes.
3. Failure to clear the antigen may lead to persistent inflammation and eventual formation
of epithelioid cells and giant cells, giving rise to a granulomatous tissue reaction.
Whatever the underlying mechanism, vascular inflammation and necrosis ensues which is
often accompanied by thrombosis. These pathologic changes result in tissue ischaemia,
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necrosis and infarction, leading to a variety of clinical manifestations depending on the
anatomic structures involved
3. Pathology
Perivascular cellular infiltration is a common histological finding in many disease entities, but
for a definitive diagnosis of vasculitis, the presence of vascular damage, particularly in the
form of fibrinoid degeneration, is necessary.
Vasculitis may involve blood vessels of varying calibers and this feature forms the basis of a
useful pathological classification of vasculitis. An infiltrate, composed of a variety of cell types,
like neutrophils, lymphocytes, and histiocytes may invade the vessel wall and the surrounding
tissue. Extravasation of red cells is a prominent feature in many vasculitides. Granulomatous
inflammation with giant cell formation is a characteristic finding in some types.
4. Classification
Vasculitis is a taxonomist’s nightmare. Diseases with diverse causes and pathology may share
the same symptomatology. On the other hand, a disease may show different histopathologic
features at different periods in its evolution. Many diseases have overlapping features and it
is impossible to formulate a classification scheme that unifies clinicopathological, etiological
and immunological features of different diseases.
4.1. Immunopathologic classification
i. Immune- complex mediated vasculitis:
• Polyarteritis nodosa
• Microscopic polyangiitis
• Hypersensitivity vasculitis
• (Leukocytoclastic vasculitis)
• Henoch-Schonlein purpura
ii. Vasculitis due to cellular hypersensitivity (Granulomatous vasculitis)
• Giant cell arteritis
• Takayasu’s arteritis
• Churg-Strauss disease (allergic granulomatosis)
• Wegener’s granulomatosis
• Isolated CNS vasculitis
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4.2. Classification based on caliber of blood vessel involved
i. Large vessel vasculitis:
• Giant cell arteritis
• Takayasu’s arteritis
ii. Medium vessel vasculitis:
• Polyarteritis nodosa
• Kawasaki disease
iii. Small vessel vasculitis:
• Microscopic polyangiitis
• Leukocytoclastic vasculitis
• Wegener’s granulomatosis
• Churg-Strauss disease
4.3. Classification based on cellular composition of the infiltrate
i. Leukocytoclastic vasculitis (LCV): Neutrophils are predominant. Cellular fragments
and nuclear debris (leukocytoclasia) are found in the infiltrate.
• Polyarteritis nodosa
• Henoch-Schonlein purpura
• Vasculitis due to drugs, infections, and connective tissue diseases
• Erythema elevatum diutinum
• Granuloma faciale etc.
ii. Lymphocytic vasculitis:
• Lupus erythematosus
• Lymphoma
• Pityriasis lichenoides
iii. Eosinophilic vasculitis :
• Churg-Strauss vasculitis
iv. Granulomatous vasculitis :
• Wegener’s granulomatosis and Churg-Strauss
v. Giant cell arteritis:
• Temporal arteritis
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• Takayasu’s arteritis
4.4. Clinical classification
i. Systemic necrotizing vasculitis :
• Polyarteritis nodosa
◦ Classical
◦ Microscopic polyangiitis
◦ Allergic granulomatosis
◦ Polyangiitis overlap
• Wegener’s granulomatosis
ii. Giant cell vasculitis
• Temporal arteritis
• Takayasu’s disease
iii. Predominantly Cutaneous small vessel vasculitis :
a. Idiopathic
b. Secondary:
• Infection: ( Streptococcus, Staph, TB, Leprosy, Hep.B and C, HIV, Subacute
bacterial endocarditis, EBV, parvovirus, Rickettsia)
• Drugs: Penicillin, sulpha, phenytoin, allopurinol, gold, thiazide, NSAIDs,
Frusemide, quinidine, thiouracils, mefloquine
• Connective tissue disease (SLE, Sjogren’s syndrome, RA, Scleroderma,
Dermatomyositis )
• Malignancy (Lymphoma, leukemia, solid organ tumors )
• Other diseases: Cryoglobulinemia, complement deficiency, alpha1 antitryp‐
sin deficiency Inflammatory bowel disease, Chronic active hepatitis, intestinal
bypass surgery, primary biliary cirrhosis,Relapsing polychondritis
c. Clinical syndromes with leukocytoclastic vasculitis:
• Henoch-Schonlein purpura
• Urticarial vasculitis
• Serum sickness
• Erythema elevatum diutinum
• Granuloma faciale
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• Hyperimmunoglobulinemia D
• Acute hemorrhagic edema of children
• Familial Mediterranean fever.
iv. Other vasculitic syndromes:
• Behcet’s disease Buerger’s disease
• Kawasaki’s disease
• Isolated CNS vasculitis
• Cogan’s syndrome
5. Immunodiagnostic approach
Primary systemic vasculitides were reclassified based on ANCA serology, the presence of
immune deposits in situ, and the size of the vessels involved. WG, MPA and CSS were
subsumed in the group of ANCA‐associated vasculitides, which are characterized clinically
by a WG, CSS or non‐granulomatous MPA inflammation commonly involving the respiratory
tract and ear–nose–throat (ENT) region and by a necrotizing pauci‐immune (= no or minimal
immune deposits) vasculitis typically affecting small‐ to medium‐sized vessels.
ANCA are a heterogeneous group of autoantibodies that can be subdivided by indirect
immunofluorescence tests (IFTs) and by enzyme‐linked immunosorbent assays (ELISAs). IFTs
can distinguish two major fluorescence patterns on ethanol‐fixed human granulocytes: one of
these patterns, classic cANCA, is highly specific for WG, while the other, perinuclear pANCA,
is commonly seen in MPA (rarely in WG), but may be detected in a wide variety of other
autoimmune conditions (e.g. systemic lupus erythematosus, rheumatoid arthritis, Felty's
syndrome and chronic inflammatory bowel diseases with associated disorders).
The clinical utility of cANCA as a diagnostic marker for WG was recently confirmed in a large
prospective European study undertaken with sera from vasculitis patients (sensitivity 60%,
specificity 95%) [6]. However, when employed as a routine screening method for WG (defined
according to ACR criteria) in patients with suspected vasculitis, the sensitivity of cANCA in a
recent prospective single‐centre study on 346 consecutive patients was only 28% (specificity
for WG: 98%). The sensitivity rose to 83% if only biopsy‐proven WG was considered [7]. A
meta‐analysis of 15 studies comprising 13 652 patients (including 736 cases of WG) yielded a
pooled sensitivity of 66% and a specificity of 98% [8]. Taken together, these data show that the
value of cANCA testing is limited by a rather low sensitivity; the greatest utility of cANCA
testing may be in patients with suspected, but not yet proven, WG. This view is supported by
a recent analysis of ANCA results in a large routine laboratory (Regional Immunology
Laboratory, Belfast, UK). The overall positive predictive value for primary systemic vasculi‐
tides was 38% for all cANCA and only 20% for all pANCA. Specificity improved when only
antinuclear antibody (ANA)‐negative samples with a high ANCA titre were considered
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(cANCA 90%, pANCA 60%) [9]. In most, but not all cases, titres correlated with disease activity.
Rising titres should alert the clinician to an increased risk of exacerbation, but are generally
not regarded as an indication for intensifying therapy [10].
ELISAs are used to specify further the target antigens of ANCA, namely proteinase 3 (PR3;
cANCA‐positive samples have a 99% specificity for WG), myeloperoxidase (MPO; 80%
specificity for MPA) [6], as well as less important target antigens such as cathepsin G, lacto‐
ferrin, lysozyme and human leucocyte elastase, which are not specific for any particular
vasculitic disorder. Whether anti‐bactericidal permeability increasing protein (BPI) ANCA
offer further diagnostic perspectives in vasculitis is still unclear [11-13].
So, ANCA are not specific for ANCA‐associated vasculitides and despite the high specificity
of cANCA/PR3‐ANCA for WG and of MPO‐pANCA for MPA, an increasing number of ‘false‐
positive’ PR3‐/MPO‐ANCA have been described [10]. More recently, we and others have
observed PR3‐ANCA in subacute bacterial endocarditis, a condition sometimes associated
with vasculitis [14]. Still, because ANCA test results are usually available before histological
analyses are completed, ANCA serology remains the most important tool in the diagnostic
repertoire for ANCA‐associated vasculitides, especially in seriously ill patients suspected of
having vasculitis. Under life‐threatening conditions, therefore, therapy should be commenced
based on clinical and serological findings! An overview of predominant immune phenomena
in systemic vasculitides associated with the hypersensitivity reaction types (and the serological
markers) is given in Table 2.
The incidence of ANCA in CSS is much lower than in WG and MPA, and their immunodiag‐
nostic significance is limited [6]. However, active CSS is characterized by increased eosinophils
in conjunction with strongly elevated IgE and eosinophil cationic protein values [15].
Furthermore, endothelial cell damage in active AAV is indicated by markedly increased serum
thrombomodulin (sTM) values [15]: in CSS, high levels of sTM correlate closely with the soluble
interleukin‐2 receptor, which has been shown to be a promising seromarker of disease activity
in WG [16].
Because intermittent infections are a major differential diagnostic problem in seriously ill AAV
patients (Table 3), a marker that distinguishes between the two conditions is urgently needed.
Procalcitonin was recently shown to be normal in active autoimmune rheumatic disorders, but
strongly elevated in concomitant bacterial infections and sepsis [17]. However, these findings
have yet to be confirmed [18].
6. The mycotic process in endocarditis
Infective endocarditis (IE) is defined as an infection of the endocardial surface of the heart,
which may include one or more heart valves, the mural endocardium, or a septal defect. Its
intracardiac effects include severe valvular insufficiency, which may lead to intractable
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congestive heart failure and myocardial abscesses. IE also produces a wide variety of systemic
signs and symptoms through several mechanisms, including both sterile and infected emboli
and various immunological phenomena [19-21].
IE develops most commonly on the mitral valve, closely followed in descending order of
frequency by the aortic valve, the combined mitral and aortic valve, the tricuspid valve, and,
rarely, the pulmonic valve. Mechanical prosthetic and bioprosthetic valves exhibit equal rates
of infection.
All cases of IE develop from a commonly shared process, as follows:
1. Bacteremia (nosocomial or spontaneous) that delivers the organisms to the surface of the
valve
aIn about 30% of patients MPO-ANCA or PR3-ANCA were detected.
bOr in the cryoprecipitates.
cIn particular in the respiratory tract.
Modified from [16].
Table 2. Differential diagnostic features of small vessel vasculitides
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2. Adherence of the organisms
3. Eventual invasion of the valvular leaflets
The common denominator for adherence and invasion is nonbacterial thrombotic endocarditis,
a sterile fibrin-platelet vegetation. The development of subacute IE depends on a bacterial
inoculum sufficient to allow invasion of the preexistent thrombus. This critical mass is the
result of bacterial clumping produced by agglutinating antibodies.
In acute IE, the thrombus may be produced by the invading organism (ie, S aureus) or by
valvular trauma from intravenous catheters or pacing wires (ie, NIE/HCIE). S aureus can
invade the endothelial cells (endotheliosis) and increase the expression of adhesion molecules
and of procoagulant activity on the cellular surface. Nonbacterial thrombotic endocarditis may
result from stress, renal failure, malnutrition, systemic lupus erythematosus, or neoplasia.
The Venturi effect also contributes to the development and location of nonbacterial thrombotic
endocarditis. This principle explains why bacteria and the fibrin-platelet thrombus are
deposited on the sides of the low-pressure sink that lies just beyond a narrowing or stenosis.
In patients with mitral insufficiency, bacteria and the fibrin-platelet thrombus are located on
the atrial surface of the valve. In patients with aortic insufficiency, they are located on the
ventricular side. In these examples, the atria and ventricles are the low-pressure sinks. In the
case of a ventricular septal defect, the low-pressure sink is the right ventricle and the thrombus
is found on the right side of the defect.
Nonbacterial thrombotic endocarditis may also form on the endocardium of the right ventricle,
opposite the orifice that has been damaged by the jet of blood flowing through the defect (ie,
the MacCallum patch).
GN, glomerulonephritis; Foc. segm. cresc, focal segmental crescentic; nd, not done; s., Streptococcus; n.i., not isolated;
cran., cranial; aneurysm., aneurysmatic; neg., negative; nd, not defined.
Reviewed and modified from [39].
Table 3. Summary of subacute bacterial endocarditis associated with PR3-ANCA
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The microorganisms that most commonly produce endocarditis (ie, S aureus; Streptococcus
viridans; group A, C, and G streptococci; enterococci) resist the bactericidal action of comple‐
ment and possess fibronectin receptors for the surface of the fibrin-platelet thrombus. Among
the many other characteristics of IE-producing bacteria demonstrated in vitro and in vivo,
some features include the following:
• Increased adherence to aortic valve leaflet disks by enterococci, S viridans, and S aureus
• Mucoid-producing strains of S aureus
• Dextran-producing strains of S viridans
• S viridans and enterococci that possess FimA surface adhesin
CMV, cytomegalovirus.
Table 4. Secondary vasculitides
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• Platelet aggregation by S aureus and S viridans and resistance of S aureus to platelet micro‐
bicidal proteins
Bacteremia (either spontaneous or due to an invasive procedure) infects the sterile fibrin-
platelet vegetation described above. BSIs develop from various extracardiac types of infection,
such as pneumonias or pyelonephritis, but most commonly from gingival disease. Of those
with high-grade gingivitis, 10% have recurrent transient bacteremias (usually streptococcal
species). Most cases of subacute disease are secondary to the bacteremias that develop from
the activities of daily living (eg, brushing teeth, bowel movements).
Bacteremia can result from various invasive procedures, ranging from oral surgery to sclero‐
therapy of esophageal varices to genitourinary surgeries to various abdominal operations. The
potential for invasive procedures to produce a bacteremia varies greatly. Procedures, rates,
and organisms are as follows:
• Endoscopy - Rate of 0-20%; coagulase-negative staphylococci (CoNS), streptococci, diph‐
theroids
• Colonoscopy - Rate of 0-20%; Escherichia coli, Bacteroides species
• Barium enema - Rate of 0-20%; enterococci, aerobic and anaerobic gram-negative rods
• Dental extractions - Rate of 40-100%; S viridans
• Transurethral resection of the prostate - Rate of 20-40%; coliforms, enterococci, S aureus
• Transesophageal echocardiography - Rate of 0-20%; S viridans, anaerobic organisms,
streptococci
Bacterial adherence to intravascular catheters depends on the response of the host to the
presence of this foreign body, the properties of the organism itself, and the position of the
catheter. Within a few days of insertion, a sleeve of fibrin and fibronectin is deposited on the
catheter. S aureus adheres to the fibrin component.
S aureus also produces an infection of the endothelial cells (endotheliosis), which is important
in producing the continuous bacteremia of S aureus BSIs. Endotheliosis may explain many
cases of persistent methicillin-susceptible S aureus (MSSA) and methicillin-resistant S aureus
(MRSA) catheter-related BSIs without an identifiable cause.
S aureus catheter-related BSIs occur even after an infected catheter is removed, apparently
attributable to specific virulence factors of certain strains of S aureus that invade the adjacent
endothelial cells. At some point, the staphylococci re-enter the bloodstream, resulting in
bacteremia [22].
Four days after placement, the risk of infection markedly increases. Lines positioned in the
internal jugular are more prone to infection than those placed in the subclavian vein. Coloni‐
zation of the intracutaneous tract is the most likely source of short-term catheter-related BSIs.
Among lines in place for more than 2 weeks, infection of the hub is the major source of
bacteremia. In some cases, the infusion itself may be a reservoir of infection.
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Colonization of heart valves by microorganisms is a complex process. Most transient bacter‐
emias are short-lived, are without consequence, and are often not preventable. Bacteria rarely
adhere to an endocardial nidus before the microorganisms are removed from the circulation
by various host defenses.
Once microorganisms do establish themselves on the surface of the vegetation, the process of
platelet aggregation and fibrin deposition accelerate at the site. As the bacteria multiply, they
are covered by ever-thickening layers of platelets and thrombin, which protect them from
neutrophils and other host defenses. Organisms deep in the vegetation hibernate because of
the paucity of available nutrients and are therefore less susceptible to bactericidal antimicro‐
bials that interfere with bacterial cell wall synthesis.
Complications of subacute endocarditis result from embolization, slowly progressive valvular
destruction, and various immunological mechanisms. The pathological picture of subacute IE
is marked by valvular vegetations in which bacteria colonies are present both on and below
the surface.
The cellular reaction in SBE is primarily that of mononuclear cells and lymphocytes, with few
polymorphonuclear cells. The surface of the valve beneath the vegetation shows few organ‐
isms. Proliferation of capillaries and fibroblasts is marked. Areas of healing are scattered
among areas of destruction. Over time, the healing process falls behind, and valvular insuffi‐
ciency develops secondary to perforation of the cusps and damage to the chordae tendineae.
Compared with acute disease, little extension of the infectious process occurs beyond the
valvular leaflets.
Levels of agglutinating and complement-fixing bactericidal antibodies and cryoglobulins are
markedly increased in patients with subacute endocarditis. Many of the extracardiac mani‐
festations of this form of the disease are due to circulating immune complexes. Among these
include glomerulonephritis, peripheral manifestations (eg, Osler nodes, Roth spots, subungual
hemorrhages), and, possibly, various musculoskeletal abnormalities. Janeway lesions usually
arise from infected microemboli.
The microscopic appearance of acute bacterial endocarditis differs markedly from that of
subacute disease. Vegetations that contain no fibroblasts develop rapidly, with no evidence of
repair. Large amounts of both polymorphonuclear leukocytes and organisms are present in
an ever-expanding area of necrosis. This process rapidly produces spontaneous rupture of the
leaflets, of the papillary muscles, and of the chordae tendineae.
The complications of acute bacterial endocarditis result from intracardiac disease and meta‐
static infection produced by suppurative emboli. Because of their shortened course, immuno‐
logical phenomena are not a part of acute IE.
W illiam Osler first used the term mycotic aneurysm in his 1885 Gulstonian Lecture series [23]
to refer to an aneurysm resulting from an infectious process of the arterial wall, although a
more accurate term might have been endovascular infection or infective vasculitis, because
mycotic aneurysms are not due to a fungal organism.
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Intracranial mycotic aneurysms (ICMAs) complicate about 2% to 3% of infective endocarditis
(IE) cases, although as many as 15% to 29% of patients with IE have neurologic symptoms
[24-26]. Of all intracerebral aneurysms, only 2% to 6% have an infectious etiology. Signs and
symptoms of mycotic aneurysms may be misleading during the early stages, resulting in
misdiagnosis and delays in treatment [27]. Early diagnosis of ICMA is the cornerstone of
effective treatment.
Mycotic aneurysms can be divided into 4 types: [1] embolic, secondary to bacterial endocarditis
(embolomycotic aneurysms); [2] extravascular, secondary to extension of contiguous infection
from a septic focus neighboring an artery; [3] cryptogenic or primary bacteremic; and [4] direct
contamination following arterial wall trauma, which may be postprocedural [28]. Aneurysms
can occur in the cerebral circulation, usually at points of vessel bifurcation, or in the systemic
circulation [29].
In IE-associated mycotic aneurysms, septic emboli are released from infected cardiac vegeta‐
tions. These tiny septic emboli occlude the vasa vasorum or entire arterial lumen, which leads
to damage to the muscular layer of the vessel. ICMA tend to occur in the more distal portions
of the middle cerebral artery, near the surface of the brain, involving the secondary and tertiary
branches. In contrast, berry aneurysms occur at proximal branch points in or near the circle of
Willis [26]. The outcome depends upon the anatomical location of the embolus, the causative
bacteria and associated virulence of the organism, underlying host defenses, and appropriate
antibiotic therapy. Mycotic aneurysms can decrease, increase, remain the same in size, or even
disappear during treatment for endocarditis [30].
Patients with bacterial intracranial aneurysms have variable neurological symptoms, and early
symptoms of infection may be subtle. In ICMA, patients may have symptoms ranging from
nonspecific, general complaints, including fever or headache, to neurological deficits or
catastrophic intracranial hemorrhage. Laboratory results are typically suggestive of an
underlying inflammatory process and may include leukocytosis, elevated erythrocyte
sedimentation rate and/or C-reactive protein concentration, and anemia. Blood cultures are
almost universally positive for microbial growth.
Computed tomographic angiography, magnetic resonance angiography (MRA), and catheter
angiography are used to study the size,  location, and morphology of intracranial  aneur‐
ysms. Aneurysms 5 mm in diameter or larger can be detected by CTA and MRA. Smaller
aneurysms are detected less reliably or detected in retrospect after comparison with cerebral
angiography.[31-33].  Cerebral  angiography  is  the  gold  standard  and  is  often  used  in
preoperative  assessment  and  in  determining  prognosis[34];  however,  it  is  not  routinely
recommended due to risk of  complications associated with it.  The size of  the aneurysm
during therapy can be safely and accurately monitored using CTA and MRA. In our patient,
CTA was selected as the diagnostic tool.
Treatment of ICMA is controversial, in that the appropriate patients for surgical intervention,
need for follow-up imaging, and most efficacious treatment are not well delineated in the
medical literature. The appropriate treatment always involves medical and sometimes surgical
therapies [35]. Moreover, there is no single uniformly accepted approach to the treatment of
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ICMA in IE. The aim of therapy is to cure the underlying infection and avoid complications
from the aneurysm. Some lesions will resolve with antibiotic therapy alone. The decision to
pursue surgical management is complex and involves a number of factors, including the
number, site, and anatomy of the aneurysm(s) and the comorbidities of the patient. Treatment
options for unruptured aneurysms include observation or surgical approaches, such as
craniotomy and clipping or endovascular coiling [36,37]. The surgical choice of treatment for
ICMA is controversial, patient-specific, and is generally beyond the scope of this article. Four-
to 6-week courses of pathogen-specific intravenous antibiotic are recommended. In addition,
medical therapy should include control of hypertension and seizures. Therapy should be
monitored with serial CTA or MRA, and surgical intervention is generally recommended for
enlarging aneurysms in accessible locations. Ruptured aneurysms are treated emergently with
surgery to prevent rebleeding if possible.
Staphylococcus aureus (~30%), Salmonella species (~15%), and less commonly viridans group
streptococci are some of the causitive organisms of mycotic aneurysms in the postantibiotic era [38].
Recent reports suggest Streptococcus pneumoniae, including penicillin-resistant strains, are re-
emerging as a cause of mycotic aneurysms [39]. Our patient was infected with Streptococcus
bovis, a gram-positive cocci classified as group D streptococci. Endocarditis is the most
significant clinical infection associated with S bovis, but bacteremia from enteric origins also
occurs. S bovis accounts for 2% to 6% of streptococcal bloodstream isolates from hospitalized
patients and for 2.4% to 25% of organisms associated with IE [40-44]. S bovis is a rare cause of
ICMA, however. Interestingly, S bovis endocarditis or bacteremia is associated with concom‐
itant undiagnosed gastrointestinal (GI) tumors in up to 56 % of patients [45]. GI diseases
associated with S bovis endocarditis include colonic cancers, gastric ulcers, gastric cancer,
duodenal ulcers, inflammatory bowel disease, colonic diverticula, angiodysplasia, and liver
cirrhosis [40,46-48]. Thus, any patient with S bovis bacteremia should undergo screening for
occult GI malignancy. Although our patient died before such screening could be completed,
he did have a family history of gastric cancer and a personal history of colon cancer.
7. Bacterial causes of vasculitis
Bacterial seeding of vessels may lead to necrosis through direct bacterial action. Vessels may
be seeded intraluminally at sites of endothelial injury or flow turbulence. Seeding of vasa
vasora may cause destruction of vessels from the outside in. An injury of a large vessel by this
mechanism is classically termed a “mycotic aneurysm.”
Contiguous spread from an infected site to a vessel may occur. Vessels may also be seeded
from within the lumen, as in subacute bacterial endocarditis in which septic emboli embed
within the wall of smaller vessels, causing a “mycotic” process via a luminal route. Immune
response to bacteria or to bacterial components may also lead to vasculitis, usually by immune-
complex–mediated mechanisms[24].
In subacute bacterial endocarditis, direct spread via septic emboli and immune complex injury
may occur.
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Patients may present with evidence of elevated acutephase reactants, fever, malaise, myalgia,
arthralgia, Osler’s nodes, Janeway lesions, and septic infarcts [49,50].
Staphylococcus and streptococcus infections are common causes. Gram-negative organisms,
other gram-positive cocci, fungi, and parasites may be causative as well, and their occurrence
depends on the clinical setting [51-57].
Mycotic aneurysms resulting from septic emboli are common with staphylococcus, streptococ‐
cus, and Salmonella species [58-60]. Patients with subacute infections may develop cryoglobu‐
lins [61-63]. Bacteremia may present as leukocytoclastic vasculitis [64, 65]. Small-vessel vasculitis
may be associated with post-streptococcal infection, distinct from endocarditis [66, 67].
The Rickettsiae are a group of obligate intracellular bacteria with tropism for vascular endo‐
thelium [68]. Infection results in widespread microvascular leak, local thrombosis, and
ultimately multisystem failure if untreated. [69, 70].
Treponema pallidum and borrelia burgdorferi are also rare causes of infectious vasculitis
[71].
In the lung, necrosis of vessels may occur from septic emboli or from contiguous spread in
primary pneumonias. In the latter setting, Pseudomonas aeruginosa and Legionella pneumophila
often cause direct necrosis via contiguous spread [72]. The presentation, however, is that of
pneumonia.
Mycobacterial or fungal pulmonary infections may mimic Wegener’s granulomatosis or
Churg-Strauss vasculitis in eliciting a granulomatous reaction in vessels [73].
Spread of Mycobacterium tuberculosis to the aorta may be seen as a cause of tuberculous aortitis,
coronary arteritis, and mycotic aneurysm [74-76]. Aspergillus aeruginosa, Aspergillus fumiga‐
tus, and Mucor may be characterized by direct vessel invasion and necrosis [59, 77, 78]
Coccidioides immitis meningitis may be associated with vasculitis that can be confused with
central nervous system
Angeitis [79, 80]. Coccidioides immitis may also present as an immune-complex–mediated
disease with erythema nodosum, periarthritis predominantly of the ankles, and bihilar
lymphadenopathy [81, 82]. This presentation is often confused with Löfgren’s syndrome of
sarcoidosis. While sarcoidosis as a cause of Löfgren’s syndrome is more prevalent in eastern
United States populations, Coccidioides immitis is a more likely cause of a Löfgren’s-like
presentation in the western United States.
Neisseria species may be associated with small-vessel vasculitis. In Neisseria gonorrhea infection,
cutaneous papules vesiculate, then becomes necrotic [83]. In N meningitides infections,
vasculitis may manifest in the skin and gastrointestinal tract with the endothelium showing
necrosis and thrombosis [84-86]. In immunocompromised hosts, Pseudomonas aeruginosa and
other gram-negative organisms can present as a large 1- to 5-cm macular erythema that
develops central necrosis and peripheral edema and induration—a condition termed “ecthyma
gangrenosum.” Vessel thrombosis results from direct bacterial invasion of the vessels. Similar
lesions may be seen in immunocompromised patients with disseminated Pseudomonas,
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Nocardia, Aspergillus, Mucor, Curvularia, Pseudallescheria, Fusarium, Morganella, Metarrhizium,
Xanthomonas, Klebsiella, E coli, and Aeromonas infections.[87-99].
Before AIDS, syphilis was the infectious agent known as the “great imposter,” presenting as
large- or medium size vessel disease (aortitis or coronary arteries) or as the small-vessel rash
of secondary lues. Aortic aneurysms were insidious in clinical presentation. Treponema
pallidum spirochetes were rarely detected in fibrosed and scarred vessels [100-102]. At least
briefly, Borrelia burgdorferi, the causative agent of Lyme disease, was known as an “imposter.”
Vasculitic changes may be seen in the central nervous system, retina, and temporal arteries
[103-116].
8. Viral causes of vasculitis
Our knowledge of viral pathogenesis has exploded in the last quarter of the twentieth century,
accelerated in large part by epidemics of “emerging” viral diseases. Hepatitis C virus,
discovered in 1989, has worldwide prevalence [25]. The10- to 20-year latent period before
hepatic or rheumatic manifestations of disease explains the increasing number of cases of
hepatitis C virus–mediated vasculitis currently being seen in the United States following the
epidemic of new infections in the 1980s [26]. Prior to the discovery and characterization of
hepatitis C virus in the late 1980s, the triad of arthritis, palpable purpura, and type II cryoglo‐
bulinemia was given the sobriquet “essential mixed cryoglobulinemia” and considered an
idiopathic vasculitis.
Availability of diagnostic testing for hepatitis C virus demonstrated that almost all of these
cases were associated with hepatitis C virus infection. Immune response to the virus elicits a
response to the Fc portion of immunoglobulin with the majority of elicited antibody having
the Wa idiotype [27,28].
Immune complexes of anti–Fc Wa idiotypic antibody and pre-existing antibody, and virus
have the peculiar physical property of precipitating out of solution in the cold (“cryoglobu‐
lins”). Presumably, Wa idiotype recognizes a cross-reactive epitope found on hepatitis C virus
and immunoglobulin. Extremities and skin are sufficiently cold so as to explain a predilection
for small-vessel leukocytoclastic vasculitis of the skin; gravity enhances vascular injury in
dependent distal vessels, giving rise to palpable purpura predominantly in the lower extrem‐
ities. More severe cases may manifest visceral organ involvement including membranoproli‐
ferative glomerulonephritis and bowel involvement. Small- and mediumsized arteries may be
involved as well, especially in the kidneys.
Hepatitis B virus (HBV) infection provides the classic example of virally mediated immune
complex disease. A lymphocytic venulitis or neutrophilic vasculitis of small vessels with
leukocytoclastic or fibrinoid changes presents typically as an “urticaria-arthritis syndrome.”[29].
Immune complexes of hepatitis B virus surface antigen (HBsAg) and antibodies to hepati‐
tis B virus surface antigen (HBsAb) circulate in the blood and are found deposited in vessels
in association with complement [30, 31]. The long latency period of HBV allows time for an
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immune  response  to  occur.  Viral  replication  increases  HBsAg  load,  and  is  temporally
associated with jaundice [32]. The immune complexes eventually no longer form in antigen
excess, and the serum sickness-like illness resolves. HBV has also been associated with large-
vessel  polyarteritis  nodosa-like illness  [33].  Onset  is  early  in  the course of  chronic  HBV
hepatitis.
Immune complexes containing HBsAg, HBsAb, and complement are found in the vessel wall
[34]. The determinants of small vessel versus larger vessel disease in the two syndromes of
HBV infection are unknown.
Human immunodeficiency virus (HIV) patients may present with a variety of vasculitides.
However, it is difficult to specifically attribute the various vasculitides seen to HIV because of
frequent co-infections with other agents that may cause vasculitis in the absence of HIV
infection.
Human T lymphotropic virus l infection may cause retinal, cutaneous, or central nervous
system vasculitis [35-38].
The herpesviruses (cytomegalovirus, varicella-zoster, herpes simplex viruses 1 and 2, and
herpes hominis) may be associated with retinal vasculitis in immunocompromised patients
[39-45]. Varicella-zoster may also cause a diffuse central nervous system small arterial
granulomatous vasculitis, or a small- and/or large-artery vasculopathy [46-48, 117]. Herpes
simplex viruses 1 and 2 have been associated with cutaneous vasculitis and necrotizing arteritis
of small and medium vessels [118-120]. Epstein-Barr virus has been suggested as a cause of
both small- and large-vessel disease in a number of cases and short series [121-126]. However,
the ability to demonstrate causality in many instances is made all the more difficult by the
latency of herpesvirus infection.
Varicella zoster virus and CMV have been as well implicated in the etiopathogenesis of various
vasculitides via numerous and overlapping mechanisms including direct microbial invasion
of endothelial cells, immune complex mediated vessel wall damage and stimulation of
autoreactive B and/or T cells through molecular mimicry and superantigens [71].
Vasculitis following varicella-herpes zoster infection occasionally develops in the form of a
central neurological deficiency (locomotor deficiency with or without aphasia around one
month after an ophthalmologic herpes zoster) or involving the retina or, more rarely, the skin
or the kidneys. Vasculitis associated with cytomegaloviral infection,predominantly observed
in immunodepressed patients, is diffuse and basically involving the digestive tube, notably
the colon, the central nervous system and the skin [127].
Parvovirus B19 has been suggested as the causative agent of Wegener’s granulomatosis and
polyarteritis nodosa in a number of cases and short series [128-133]. However, the issue of
latency and the failure to eliminate B19 from pooled blood products provides a cautionary
note when considering causality [134-137]. Rare cases of vasculitis have similarly been reported
following rubella virus, adenovirus, echovirus, coxsackievirus, parainfluenza virus, herpes
simplex viruses, and hepatitis A virus infections [23, 138-148].
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Ziegler et al demonstrated the presence of vasculitis in infected falcons by the West Nile virus.
West Nile virus (WNV) is a zoonotic flavivirus that is transmitted by blood-suckling mosqui‐
toes with birds serving as the primary vertebrate reservoir hosts (enzootic cycle). Some bird
species like ravens, raptors and jays are highly susceptible and develop deadly encephalitis
while others are infected subclinically only. Pathological findings in infected birds consistently
included splenomegaly, non-suppurative myocarditis, meningoencephalitis and vasculitis. By
immunohistochemistry WNV-antigens were demonstrated intralesionally. These results
impressively illustrate the devastating and possibly deadly effects of WNV infection in falcons,
independent of the genetic lineage and dose of the challenge virus used. Due to the relatively
high virus load and long duration of viremia falcons may also be considered competent WNV
amplifying hosts, and thus may play a role in the transmission cycle of this zoonotic virus.
Rare cases of vasculitis have similarly been reported following rubella virus, adenovirus,
echovirus, coxsackievirus, parainfluenza virus, herpes simplex viruses, and hepatitis A virus
infections [23, 138-148].
9. Parasitic causes of vasculitis
Toxocara canis presented in an adolescent as palpable purpura with additional features
suggesting Henoch-Schönlein purpura [149]. Cysticercus has caused vasculitis and arachnoi‐
ditis as it infects the central nervous system [150] Angiostrongylus nematodes apparently
caused a Wegener’s granulomatosis-like pulmonary angiitis [151]. Loa loa, a filarial parasite,
presented with cutaneous leukocytoclastic vasculitis
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